A Cure in Sight
for Blindness
Retina South Africa is the only patient group in South Africa dedicated to bringing promising clinical trials and treatments to South Africa. We offer free counselling, education, information and referrals to patients with retinal genetic vision loss and facilitate genetic testing.
LEARN MOREHow We Can Help
Research progress in genetics, stem cells, artificial vision and other exciting fields are fulfilling the dream of treatments for retinal genetic conditions such as Macular Dystrophies, Stargardt Dystrophy, Retinitis Pigmentosa, Usher Syndrome and Age Related Macular Degeneration, Retina South Africa is dedicated to ensuring access to this dream for all South Africans.
Help line 0860595959 (SA only) or +27114501181
The Latest News
News
James Cape – Retina SA Chairman 2006-2021
James Cape – Retina SA Chairman 2006-2021
It is with great sadness that we bring you the news of the passing of our dear Chairman, James Cape.
James spent the last 35 years working to ensure that clinical trials and treatments will be accessible to all South Africans with retinal vision loss.
News
Clinical Trials Day – 20 May 2021
How did an 18th century British naval doctor helped us beat the Corona Virus ?
Retina South Africa would like to pay tribute to the thousands of dedicated clinical researchers who work so hard to bring treatments and new therapies to patients worldwide in every area of health and disease.
News
Getting into QR Codes
QR codes are the square blocks with a strange pattern that are being used more frequently for many online transactions and for navigation.
News
Bionic Sight’s Optogenetic Therapy
This exciting research enables blind patients to detect light and motion in an early trial. The therapy is designed to work for people with advanced vision loss, independent of the mutated gene causing the retinal disease.
News
News from ProQR
Retinitis Pigmentosa and Usher Syndrome – ProQR has announced positive results of their Usher syndrome and retinitis pigmentosa clinical study Stellar, which has met all its stated objectives. This marks a crucial milestone in their ongoing inherited retinal disease research.